Risk, Responsibility, and Generic Drugs
نویسندگان
چکیده
منابع مشابه
Serostatus, risk and responsibility
Rises in new HIV infections and the return of the hyper-epidemics of sexually transmissible infections have occurred among gay men in North America, Western Europe, Australia and New Zealand. If you look beneath the surface, discourses of failed responsibility and blame are a common reaction among gay men, educators, doctors and governments. When HIV first spread among gay communities in the la...
متن کاملThe concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
Time and again the importance of generic prescribing has been emphasized, primarily to reduce the cost of drugs (Mukherjee, 2013). There are two concepts to be understood here, one is generic vs. patented drugs and the other is a drug’s “brand name” vs. “non-proprietary name” or “generic name.” Although, our article primarily describes the Indian scenario, it can be extrapolated to other countr...
متن کاملBioequivalence of generic drugs.
Generic drugs are bioequivalent to the original brand; this is a prerequisite for marketing approval. It is theoretically possible that one generic drug may overestimate the pharmacokinetic (PK) parameters of the original and another generic may underestimate these PK parameters; in consequence, these 2 generics may not be bioequivalent between themselves. The result could be loss of efficacy o...
متن کاملPharmacists' responsibility and potential liability regarding generic substitition.
The generic medicines market in Australia is continuously growing and there is a push by the government towards generic substitution. However, generic dispensing places additional time constraints on pharmacists. There is also an increased need for professional judgement, and hence increased risk of error. Generic dispensing consequently places an increased responsibility on pharmacists, with a...
متن کاملGeneric versus brand-name drugs
What?s in a name? A brand-name drug and its generic counterpart are chemically the same. They may have different names, colors, and shapes, but the United States Food and Drug Administration (FDA) requires generic drugs to share several similarities as the brand-name counterparts (more on this later). And, while there are some differences, generics don?t really change the effectiveness of the d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: New England Journal of Medicine
سال: 2012
ISSN: 0028-4793,1533-4406
DOI: 10.1056/nejmp1208781